Sep 27, 2022 / NTS GMT
Mats Hyttinge - Redeye AB - Analyst
Welcome back. We now have Simon Grant, CEO of SciBase, with us. Welcome, Simon.
Simon Grant - SciBase Holding AB(publ)-CEO
Thank you, Mats. SciBase is based here in Stockholm and we are a company working within skin diagnostics, within dermatology primarily. And we have been a pioneer within artificial intelligence. We had one of the first products to ever be released and definitely to be FDA approved. And that product has gone on to be used more than 150,000 times clinically.
We are a commercial-stage company. We're past the stage of technical regulatory and clinical risk. And we're growing quite well. We are up about 65% this year, year to date. We have been growing in our key markets, Germany and the US, especially in the US, but in both markets. And we see a good growth going forward as well.
One thing is that we have reached a really important goal for us this year, and that is to reach 70% in gross margin. So things are going quite well and we have momentum on the sales
SciBase Holding AB (publ) at Redeye Diagnostics Seminar Transcript
Sep 27, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers